EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Peptide-derived gold nanoparticles as a promising delivery system for Src targeting siRNA in breast cancer cells

Uday Suryakanta, Bijayananda Panigrahi, Sumana Pal, Swatilekha Das, Soumyadeep Biswas, Dindyal Mandal

RSC Pharmaceutics · 2025 · 2 (3) · 581-597

DOI: 10.1039/d4pm00249k ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Pharmaceutics, 2025. Verfasst von Uday Suryakanta und 5 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Indian Council of Medical Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gold nanoparticles were efficiently synthesized using linear peptides consisting of Trp & Arg residues, where (W4R4)-capped AuNPs exhibited efficient siRNA internalization, and Src protein silencing in MCF-7 cells.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Suryakanta, U., Panigrahi, B., Pal, S., Das, S., Biswas, S., & Mandal, D. (2025). Peptide-derived gold nanoparticles as a promising delivery system for Src targeting siRNA in breast cancer cells. RSC Pharmaceutics, 2(3), 581-597. https://doi.org/10.1039/d4pm00249k

Vancouver

Suryakanta U, Panigrahi B, Pal S, Das S, Biswas S, Mandal D. Peptide-derived gold nanoparticles as a promising delivery system for Src targeting siRNA in breast cancer cells. RSC Pharmaceutics. 2025;2(3):581-597. doi:10.1039/d4pm00249k

BibTeX
@article{Suryakanta2025,
  author = {Suryakanta, Uday and Panigrahi, Bijayananda and Pal, Sumana and Das, Swatilekha and Biswas, Soumyadeep and Mandal, Dindyal},
  title = {Peptide-derived gold nanoparticles as a promising delivery system for Src targeting siRNA in breast cancer cells},
  journal = {RSC Pharmaceutics},
  year = {2025},
  volume = {2},
  number = {3},
  pages = {581--597},
  doi = {10.1039/d4pm00249k}
}
Kostenlos starten →